4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Daito Pharmaceutical Co.,Ltd. (4577) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toyama, Japan. Its market capitalization is roughly JPY 37 billion.
Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs.
Interactive charts & full statements →
| Income statement | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Total Revenue | — | JPY 50.6B | JPY 46.9B | JPY 45.1B | JPY 43.5B |
| Gross Profit | — | JPY 8.6B | JPY 9.8B | JPY 10.3B | JPY 11.5B |
| Operating Income (EBIT) | — | JPY 2.6B | JPY 3.9B | JPY 5.2B | JPY 6.6B |
| Net Income | — | JPY 1.9B | JPY 3.3B | JPY 3.6B | JPY 4.7B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Dividends Paid | (JPY 998M) | (JPY 907M) | (JPY 931M) | (JPY 660M) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Total Assets | JPY 78.0B | JPY 77.7B | JPY 70.6B | JPY 64.9B |
| Total Liabilities | JPY 25.9B | JPY 25.4B | JPY 19.6B | JPY 17.3B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4577 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms